The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)
- PMID: 10449515
- PMCID: PMC2195605
- DOI: 10.1084/jem.190.4.445
The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)
Figures
Comment on
-
Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts.J Exp Med. 1999 Aug 16;190(4):451-59. doi: 10.1084/jem.190.4.451. J Exp Med. 1999. PMID: 10449516 Free PMC article.
Similar articles
-
Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts.J Exp Med. 1999 Aug 16;190(4):451-59. doi: 10.1084/jem.190.4.451. J Exp Med. 1999. PMID: 10449516 Free PMC article.
-
Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.J Environ Pathol Toxicol Oncol. 2002;21(2):155-64. J Environ Pathol Toxicol Oncol. 2002. PMID: 12086402 Review.
-
Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.J Pharmacol Exp Ther. 1997 Feb;280(2):606-13. J Pharmacol Exp Ther. 1997. PMID: 9023270
-
Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.J Environ Pathol Toxicol Oncol. 2002;21(2):193-201. J Environ Pathol Toxicol Oncol. 2002. PMID: 12086406 Review.
-
Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.Can J Physiol Pharmacol. 1997 Sep;75(9):1088-95. Can J Physiol Pharmacol. 1997. PMID: 9365818
Cited by
-
Carcinogenesis: Failure of resolution of inflammation?Pharmacol Ther. 2021 Feb;218:107670. doi: 10.1016/j.pharmthera.2020.107670. Epub 2020 Sep 3. Pharmacol Ther. 2021. PMID: 32891711 Free PMC article. Review.
-
The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites.EMBO J. 2010 Oct 6;29(19):3395-407. doi: 10.1038/emboj.2010.197. Epub 2010 Aug 17. EMBO J. 2010. PMID: 20717101 Free PMC article.
-
Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice.PLoS One. 2019 Nov 6;14(11):e0224309. doi: 10.1371/journal.pone.0224309. eCollection 2019. PLoS One. 2019. PMID: 31693710 Free PMC article.
-
Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia.Invest New Drugs. 2008 Apr;26(2):139-49. doi: 10.1007/s10637-007-9106-z. Epub 2007 Dec 20. Invest New Drugs. 2008. PMID: 18094935 Clinical Trial.
-
Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study.Cancer Causes Control. 2010 Sep;21(9):1503-12. doi: 10.1007/s10552-010-9579-5. Epub 2010 May 25. Cancer Causes Control. 2010. PMID: 20499154 Free PMC article.
References
-
- WHO . The World Health Report. World Health Organization; Geneva, Switzerland: 1997.
-
- Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159–170. - PubMed
-
- Shiff S.J., Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancerevolving concepts of their chemopreventive actions. Gastroenterology. 1997;113:1992–1998. - PubMed
-
- Takayama T., Katsuki S., Takahashi Y., Ohi M., Nojiri S., Sakamaki S., Kato J., Kogawa K., Miyake H., Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N. Engl. J. Med. 1998;339:1277–1284. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources